[{"AccountsPayableCurrent_0_Q2_USD":2536000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":2000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":3183248.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":993000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1322000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":2560000.0,"OtherLiabilitiesCurrent_0_Q2_USD":146000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":63395000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":15.72,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":14.76,"OperatingCostsAndExpenses_1_Q2_USD":16454000.0,"OperatingCostsAndExpenses_2_Q2_USD":28833000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":9.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q2_shares":63389.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":121000.0,"InvestmentIncomeInterest_2_Q2_USD":740000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-16162000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-27997000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2_Q2_USD":0.46,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_Q2_shares":91760.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":261983000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-472000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":1322000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.62,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":50665000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":194500.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":1220.0,"InvestmentIncomeInterest_1_Q2_USD":247000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":50665000.0,"MarketableSecurities_0_Q2_USD":89059000.0,"MarketableSecuritiesCurrent_0_Q2_USD":39586000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":24781000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":67000.0,"OperatingLeasePayments_1_Q2_USD":59000.0,"OperatingLeasePayments_2_Q2_USD":118000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":45000.0,"MarketableSecuritiesUnrealizedGainLoss_2_Q2_USD":96000.0,"LeaseCost_1_Q2_USD":86000.0,"LeaseCost_2_Q2_USD":180000.0,"LandSubjectToGroundLeases_0_Q2_sqft":6647.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q2_USD":88969000.0,"CommonStockDividendsPerShareCashPaid_2_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-1453000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":102833000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":49473000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":89059000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedGain_2_Q2_USD":90000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1_Q2_USD":13000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":62000.0,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":7.64,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":158000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":634716.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":6450399.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-158413000.0,"ProfitLoss_2_Q2_USD":-28093000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":158000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":10360000.0,"NetIncomeLoss_1_Q2_USD":-16207000.0,"NetIncomeLoss_2_Q2_USD":-28093000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-33901000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":32184000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":264000.0,"LiabilitiesCurrent_0_Q2_USD":10393000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":114058000.0,"Liabilities_0_Q2_USD":10395000.0,"StockholdersEquity_0_Q2_USD":103663000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":9419000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3417000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":7005000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.57,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.98,"CommonStockValue_0_Q2_USD":3000.0,"CommonStockSharesOutstanding_0_Q2_shares":28683679.0,"CommonStockSharesIssued_0_Q2_shares":28683679.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":63247000.0,"AssetsCurrent_0_Q2_USD":113193000.0,"Assets_0_Q2_USD":114058000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":3246637.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":90000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1589000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":28551227.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":28602976.0,"CommitmentsAndContingencies_0_Q2_USD":null,"SecurityDeposit_0_Q2_USD":20000.0,"OtherAssetsNoncurrent_0_Q2_USD":865000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":15963000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":22.45,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.14,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":9.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3183248.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":247000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":740000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":184000.0,"WeightedAverageNumberOfSharesRestrictedStock_1_Q2_shares":70244.0,"WeightedAverageNumberOfSharesRestrictedStock_2_Q2_shares":54971.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":9000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":106587.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.0044,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0107,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.744,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.777,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensation_2_Q2_USD":2560000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":13037000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":21828000.0,"OperatingIncomeLoss_1_Q2_USD":-16454000.0,"OperatingIncomeLoss_2_Q2_USD":-28833000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":10969000.0,"UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_0_Q2_USD":4891000.0,"Ticker":"AKRO","CIK":"1744659","name":"AKERO THERAPEUTICS, INC.","OfficialName":"Akero Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"399847718.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200812"}]